• SmartestCrowd
    • No organizations
    • No projects
0
0
Study finds among outpatients with mild to moderate COVID-19, treatment with fluvoxamine does not reduce duration of symptoms - News-Medical.Net
11/22/23 at 4:15pm
Organization
News-Medical.Net
38 words
0
Comments
Researchers investigate the effects of high-dose fluvoxamine among patients with mild-to-moderate COVID-19.
You are the first to view
https://www.news-medical.net/news/20231122/Study-finds-among-outpatients-with-mild-to-moderate-COVID-19-treatment-with-fluvoxamine-does-not-reduce-duration-of-symptoms.aspx
Create an account or login to join the discussion